Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ambenonium (WIN 8077) is a competitive and reversible cholinesterase AChE inhibitor with the advantage of being orally available with an IC50 = 0.7 nM for the treatment of myasthenia gravis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $293 | 6-8 weeks | |
5 mg | $722 | 6-8 weeks | |
10 mg | $987 | 6-8 weeks | |
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Ambenonium (WIN 8077) is a competitive and reversible cholinesterase AChE inhibitor with the advantage of being orally available with an IC50 = 0.7 nM for the treatment of myasthenia gravis. |
Targets&IC50 | BChE (human):8.2 μM, AChE (human):0.0007 μM |
In vitro | Ambenonium inhibited human AChE with high potency (IC₅₀ = 0.0007 μM; Ellman’s method; 20 min incubation), and showed strong selectivity over BChE (IC₅₀ = 8.2 μM)[1]. |
Alias | WIN8077, WIN 8077 |
Molecular Weight | 537.57 |
Formula | C28H42Cl2N4O2 |
Cas No. | 7648-98-8 |
Smiles | O=C(NCC[N+](CC=1C=CC=CC1Cl)(CC)CC)C(=O)NCC[N+](CC=2C=CC=CC2Cl)(CC)CC |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.